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Abstract: The left and right ventricles of the four-chambered heart have distinct developmental
origins and functions. Chamber-specific developmental programming underlies the differential gene
expression of ion channel subunits regulating cardiac electrophysiology that persists into adulthood.
Here, we discuss regional specific electrical responses to genetic mutations and cardiac stressors,
their clinical correlations, and describe many of the multi-scale techniques commonly used to analyze
electrophysiological regional heterogeneity.
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1. Introduction
The evolution of species from the sea onto land required the ability to oxygenate blood in
the lungs. Coincident with the need for a pulmonic circulation, the embryo developed a way of
recruiting additional cells into the heart to form the second ventricle. While the left ventricle (LV)
is derived from cells within the first heart field, the cells that ultimately form the mature right
ventricle (RV) derive from a distinct progenitor population defined as the second heart field. It is well
known that LV and RV cardiomyocytes have distinct transcriptional profiles during development,
and that their transcriptional profiles become more similar in the adult heart [1]. However, given that
their progenitors are subjected to different signaling pathways throughout development, LV and RV
transcriptional differences are often accentuated in response to genetic mutations or stress [2]. In this
commentary, we will discuss how developmental programming can affect regional electrophysiology
(EP) and arrhythmia predisposition, and we will delineate some of the techniques used to study
regional heterogeneity within the heart.
2. Developmental Signals Regulating LV-RV Cardiomyocyte Programming
First and second heart field patterning is controlled by distinct transcriptional networks, with
pathways, such as Hand1, predominantly active in the first heart field, while Hand2 and Wnt
signaling play important functions during second heart field development [3–5]. Changes in chromatin
accessibility throughout development and aging may, at least in part, explain why the timing of
transcription factor expression is crucial. For example, activation of a signaling pathway may program
a distinct cellular subtype during embryogenesis, while reactivation of the same pathway in the adult
may result in only a partial phenotypic conversion. Activation of either neuregulin-1 or Notch is
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sufficient to convert embryonic ventricular myocytes into Purkinje cells, while in the adult, there
is a more limited transcriptional response and only a subset of Purkinje-enriched ionic currents are
modulated [6–9].
In addition to the importance of timing, regional developmental programming may result in
distinct chamber-specific electrophysiological responses. To highlight one example, we performed
single cell voltage clamp experiments on dissected left versus right ventricular tissue in Notch activated
hearts and observed different electrical responses. While activation of Notch signaling prolongs the
action potential duration (APD) and downregulates voltage-gated potassium currents in the LV,
no change in APD or K+ current density was observed in the RV [8]. These electrical changes are
mediated, at least in part, through altered transcription and epigenetic changes to the promoters
of subunits encoding the ion channels. Coincident with the observed chamber-specific differences
in ion channel subunit expression, activation of Notch upregulates the transcriptional repressor
Hairy-related transcription factor 2 (Hrt2, also known as Hey2) in the LV as expected, given that Hey2
is a direct Notch target. In contrast, unexpectedly, Notch activation in the RV downregulates Hey2
expression [8]. Our initial gene expression analysis conducted on pooled ventricular tissue from
Notch-activated mice did not reveal changes in Hey2 expression due to discordant chamber effects,
and it was only after separating LV from RV that these chamber-specific effects were observed. This
example underscores the idea that separately interrogating distinctly programmed regions, such as
the LV and RV, may result in different insights. Interestingly, genome-wide association studies have
implicated variants near several ion channels, as well as the 6q22.31 locus near HEY2 with Brugada
syndrome (BrS) [10]. BrS is characterized by ST-segment elevation and a propensity for sudden death
due to RV-predominant arrhythmias. Therefore, a more precise understanding of how Notch and Hey2
regulate chamber-specific ion channel gene expression may yield important translational insights.
3. Diseases Associated with a Ventricular Chamber Predilection
It is well known that the LV and RV have distinct geometries and mechanical properties suited for
either pumping blood against high systemic pressures to the body versus against lower pressures to
the lungs. This concept is highlighted in a rare congenital cardiac malformation, congenitally corrected
transposition of the great arteries (ccTGA), where both the atrioventricular and ventriculoarterial
connections are discordant [11]. In this anomaly, the right atrium (RA) connects to the morphologic LV
and pulmonary artery, and the left atrium connects to the morphologic RV and aorta [12]. While this
structural malformation is compatible with survival into adulthood, the morphologic RV functions as
the systemic pumping chamber. Given the inherent differences in morphologic LV and RV function,
over time, systemic pressures in the morphologic RV lead to hypertrophy and subsequently to failure
of the systemic ventricle [13].
In addition to properties that confer mechanical differences, unique transcriptional signatures of
ion channel subunits confer distinct electrical functions to the LV and RV. This concept has emerged
clinically with respect to genetic mutations specifically affecting one ventricle of the heart, despite all
ventricular myocytes possessing the same genome. One disease that highlights differences between LV
and RV cardiomyocytes is arrhythmogenic cardiomyopathy (ACM), a heritable condition predisposing
to ventricular arrhythmias and sudden cardiac death. ACM was predominantly considered an
RV-dominant disease, otherwise known as Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC), until about a decade ago. Two more subtypes of ACM, biventricular ACM and LV-dominant
ACM, have been identified and studied in the last few years, however, ARVC is still considered the
most dominant subtype [14]. ARVC is characterized by fibro-fatty infiltrations, RV dilation, and
arrhythmias originating from the RV [15]. Mutations in genes encoding desmosomal proteins are
attributed as the genetic cause of ARVC, and recent studies have provided insight into the mechanism
underlying how these genetic mutations give rise to ARVC [16]. Although much is still not understood
about why this heritable disease tends to affect RV over LV, it underscores that there are distinct
identities and signature roles for LV and RV cardiomyocytes in electrophysiologic homeostasis [16,17].
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The final section of this review will describe various EP techniques that can be used to investigate
cardiac electrical properties from single cells to the whole heart in both health and in diseases, such
as ARVC.
4. Techniques to Study Regional Electrophysiological Differences
4.1. Multi-Scale Assessment of Cardiac Electrical Properties
Cardiomyocytes are excitable cells due to the movement of ions across the cell membrane.
This ionic movement causes changes in membrane voltage, resulting in the cardiac action potential
(AP). Cardiomyocytes are electrically coupled to each other through gap junctions, which allow the AP
of a single cell to electrically stimulate a neighboring cell and ultimately to propagate throughout the
cardiac tissue. Distinct regional expression of ion channels leads to the LV AP waveform morphology
being distinguishable from that of the RV, and even the AP morphologies within the same chamber
differ depending on location within the chamber wall (i.e., subepicardium vs. midmyocardium vs.
subendocardium). These baseline differences in regional cardiac EP confer a unique susceptibility to
arrhythmia predisposition in diseased states when ion channel function is affected.
Arrhythmias develop when electrical impulse activation and/or propagation are disrupted.
For instance, atrial fibrillation is an arrhythmia in which ectopic electrical foci or “triggers” originate
near the pulmonary veins. Due to impairments in the left atrial electrical substrate, reentrant circuits
continuously activate the atrial myocardium much faster than what occurs during sinus rhythm.
The vulnerability of the atrium to fibrillate in response to ectopic foci is influenced by factors including
tissue architecture, such as size of the left atrium and presence of fibrosis, as well as intrinsic properties
of the cardiomyocytes affecting impulse propagation (sodium current and gap junction expression)
and action potential duration [18]. There are multiple scales for assessing the contributors that give
rise to an arrhythmic substrate at a chamber-specific level, including single cell analysis, cardiac slices,
cardiac wedges, and intact whole hearts. We later discuss the techniques used to measure regional
heterogeneity in normal and diseased hearts, the advantages and disadvantages of each method, and
discuss under which experimental circumstances each technique might be useful.
4.2. Isolated Cardiomyocytes
Regional EP heterogeneity can be measured by isolating cardiomyocytes from different chambers
through tissue digestion with enzymes to break down the extracellular matrix and connective tissues,
followed by micro-dissection. Using this technique, one can perform expression studies along with
isolated patch clamp recording to characterize EP parameters, such as individual ionic currents
and APs. Alterations to AP characteristics such as resting membrane potential, dVm/dtmax (maximal
upstroke velocity, or the slope of phase 0 of the cardiomyocyte AP mainly dictated by Na+ current),
AP amplitude, and APD at multiple stages of repolarization, can provide insight into which ionic
currents may be altered in an experimental model. There are several types of single cell patch clamp
configurations one can use (whole cell, outside-out patch, perforated patch, etc.) depending on the
experimental question. In-depth descriptions of EP principles and an overview of the single cell patch
clamp methods are available, and are outside the scope of this review [19].
Recent studies have further probed EP heterogeneity by isolating cardiomyocytes from different
layers of the chamber walls, therefore allowing characterization of EP properties of subepicardial,
midmyocardial, and subendocardial myocytes separately [20,21]. It has been previously shown
that these cardiomyocyte populations have distinct AP waveform morphologies and may, therefore,
be differentially affected in disease states. For instance, BrS has been associated with dysregulation
of the transcription factor HEY2, which affects the expression of subunits comprising the outward
K+ current, Ito [20]. Using isolated single cells to separate the subepicardium and subendocardium
of the RV in Hey2+/− heterozygous knockout mice, Veerman et al. determined that loss of Hey2
differentially affects subepicardial cardiomyocytes, resulting in their EP properties becoming more like
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subendocardial cardiomyocytes [20]. Without separating the different parts of the RV wall, changes
in the transmural EP gradient would not have been identified. Recent studies are applying similar
techniques to understand how ionic currents are differentially regulated between cardiac chambers in
normal and diseased states in humans. For example, Johnson and Springer et al. utilize this technique
to demonstrate that the transient K+ current, Ito,fast, which is normally differentially regulated across
the chamber wall in non-failing human LV, is remodeled specifically in failing LV subepicardial
cardiomyocytes leading to attenuation of the normal transmural gradient [21].
The advantages of using isolated cardiomyocytes include the ability to analyze cells from all
layers of the cardiac wall within the same animal. Furthermore, one can isolate cells from regions
of the heart anatomically difficult to access using tissue preparations, such as pacemaker cells from
the sinoatrial node (SAN) or Purkinje cells within the ventricle. Single-cell isolation is the primary
technique used to study specific ionic currents in the heart, however, the enzymatic digestion is harsh
on cell viability and can alter the cellular expression profile and/or partially digest transmembrane
proteins altering ionic currents. Another disadvantage is loss of endogenous physical and electrical
coupling with nearby cells, which ultimately influences cellular EP properties. To overcome this
disadvantage, a novel technique, known as loose patch photolysis, was recently developed by the
Escobar laboratory that enables ionic currents and kinetics to be measured in intact tissues [22]. Sharp
microelectrode recordings, detailed later in this review, also allow for single-cell EP measurements at
the tissue and organ level.
4.3. Organotypic Cardiac Slices
Recently, there has been increasing interest in the use of organotypic slices as a model system
for studying cardiac physiology. Unlike isolated cardiomyocytes, tissue architecture and electrical
coupling with surrounding cells is maintained in cardiac slices, thereby allowing measurements
of impulse propagation. Cardiac slices are typically between 100–400 µm, and given the diffusion
limits of oxygen through tissue, slice viability can be maintained via superfusion, eliminating the
need for vascular perfusion. Organotypic cardiac slices have been studied from small and large
animals including mice, rats, guinea pigs, rabbits, dogs, and pigs, as well as from human heart
biopsies and human hearts not suitable for transplantation [23–25]. Many organotypic slices can be
obtained from a single heart from multiple locations within the LV and RV chamber walls, which
allows regional-specific physiological studies from the same heart. Recent methodology for culturing
cardiac slices while maintaining electrical viability has opened new avenues for therapeutic discovery
and mechanistic testing in electrically mature human tissue, with potential applications including
acute and chronic drug studies and gene therapy approaches [24]. While slices can be used to study
cardiac conduction and APD, the tissue volume is not sufficient for studying arrhythmia mechanisms.
In addition, donated human hearts unsuitable for transplantation are an extremely precious resource,
and the unpredictable availability and infrastructure required for rapid procurement for subsequent
physiologic studies are potential barriers for widespread adoption.
4.4. Cardiac Wedge Preparations
Similar to the cardiac slice preparation, wedge preparations preserve the native tissue architecture
with the advantage of traversing the entire thickness of the chamber, thereby accommodating studies
which include arrhythmia inducibility. Major drawbacks include the need for a coronary artery
for cannulation and perfusion of oxygenated physiologic solution, thereby limiting its use on atrial
preparations and its use on small animals. In addition, while cardiac slices can be cultured for multiple
days, a cardiac wedge is viable for hours, thus imposing time limitations on experiments.
4.5. Intact Whole Hearts
Langendorff-perfused whole hearts can be used to study cardiac physiology and arrhythmia
susceptibility, and in some instances, provide the most relevant ex vivo model. Sick Sinus Syndrome
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(SSS), otherwise known as SAN dysfunction, is characterized by a slow heart rate, sinus pauses, and
susceptibility to supraventricular tachycardia [26]. Several genetic and pacing-induced models of SSS
have been generated and characterized via patch clamp recordings performed on isolated SAN cells,
and these experiments delineated alterations in ionic currents within the SAN cells responsible for the
slow heart rate [27,28]. In contrast, a recent study by Qiao and Lipovsky et al. found that in a model of
Notch-induced SSS, the SAN itself is not the main contributor to the disease phenotype [29]. In this case,
decreased excitability of the atrial myocardium prevents the SAN “source” from efficiently activating
the atrial “sink”. We performed a series of experiments including sharp microelectrode intracellular
recordings on atrial myocardium of Langendorff-perfused hearts to demonstrate altered excitability,
and programmed stimulation to demonstrate susceptibility to supraventricular tachycardia, while
single-cell isolation of SAN cells would not have identified the primary alteration underlying SSS in
this model.
4.6. Sharp Microelectrode Intracellular Recordings on Intact Cardiac Tissue
Like isolated cardiomyocyte recordings, sharp microelectrode intracellular recordings are used to
probe the electrical activity at a single-cell level. However, sharp microelectrode recordings can be
performed on intact tissue. The microelectrodes used are called “sharp” because they penetrate the cell
membrane without significant damage to cellular function as the membrane quickly seals itself around
the microelectrode. Sharp microelectrodes allow one to assess the EP characteristics of tissue slices,
wedges, or intact hearts by impaling a single cell and measuring APs of that particular cell without
subjecting the tissue to a digestion protocol. The AP characteristics mentioned previously that can be
obtained when doing single cell patch clamping can also be measured using sharp microelectrodes on
intact tissue. For example, as mentioned above, Qiao and Lipovsky et al. utilized sharp microelectrode
intracellular recordings on Langendorff-perfused intact mouse hearts to demonstrate that the dVm/dtmax
of atrial cardiomyocytes is significantly slower after transient induction of Notch signaling, suggesting
a functional impairment in Na+ current [29]. Notch induction reduces Scn5a expression in the right
atrial myocardium, and since mutations within Scn5a have been linked to familial SSS, this is a plausible
mechanism for heart rate slowing after transient Notch activation [30]. Addition of pharmacologic
agents to the superfusate or perfusion solution of slices, wedges, or intact hearts followed by sharp
microelectrode recordings can further probe how drugs affect AP morphology [31,32]. While significant
information on AP characteristics can be measured using sharp microelectrodes, impulse propagation,
and activation patterns of the heart are not visualized.
4.7. Optical Mapping
While recording EP parameters from single cells provides key insights, optical mapping is
a technique that can be used to assay EP parameters in cardiac slices, wedge preparations, and
whole-organ level physiology. Using voltage-sensitive dyes and high-speed cameras, optical APs can
be measured with high spatial and temporal resolution without the need for recording electrodes [33].
In addition to the use of dyes to track membrane potential, calcium-handling dyes can also be utilized
to provide nearly real-time imaging of calcium flux [24]. In Langendorff-perfused heart preparations,
optical mapping can delineate baseline activation and repolarization patterns during sinus rhythm,
providing information with respect to both time and space. Visualization of these patterns is achieved
with an isochrone map which utilizes a color scale to represent activation times; therefore, regions
of tissue activating at the same time are shown as the same color (isochrones). Further programmed
stimulation of specific regions of the heart during the mapping protocol can interrogate parameters
such as local conduction velocity (CV) and effective refractory periods (ERPs). Alterations in these
parameters can predispose to arrhythmias, which can be further elicited via optical mapping using
more aggressive stimulation protocols [29,34].
Optical mapping of genetically mutant mouse hearts has been used extensively to study
regional-specific conduction abnormalities [35]. For example, after observing an abnormal ECG
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pattern indicative of slowed ventricular activation in mice where the Wnt signaling pathway was
activated during development, Gillers et al. used optical mapping to directly investigate the total
epicardial activation time as well as CV within both ventricular chambers. While CV was decreased in
both the LV and RV of Wnt activated mice, the RV was much more severely affected (Figure 1) [35].
Future experiments may provide more insight into mechanisms for how developmental programming
influences these Wnt-mediated chamber-specific electrophysiologic effects.
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GOF (F,G) mice. (H) Left ventricular (LV) longitudinal conduction velocity of Wnt GOF mice was 
slower during stimulation at each cycle length, and the difference between the two genotypes became 
larger at faster pacing rates (111 and 100 ms cycle lengths, n = 4). (I) Right ventricular (RV) 
longitudinal conduction velocity of Wnt GOF mice was also slower, and was more severely decreased 
than in the LV. One Wnt GOF mutant had an electrically inexcitable RV when paced at 143 ms cycle 
length, while two others had markedly decreased conduction velocity at slower cycle lengths and 
became inexcitable at pacing rates above 125 ms cycle interval. This is consistent with decremental 
conduction, a property of AV canal and AV nodal tissues. Note the different time scales between each 
experiment. Data are represented as mean ± SEM. Group comparison for conduction velocity was 
performed using a Student’s unpaired 2-tailed t-test at each cycle length. Group comparison for 
inexcitability was performed using a Chi squared test without Yate’s correction. * p < 0.05. Modified 
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Figure 1. Ectopic Wnt activation differentially affects the electrical phenotype of RV versus LV.
(A,B) Reconstructed electrical activation pattern from optical mapping experiment during sinus rhythm
in control (A) and Wnt GOF (B) mice. (C) Total epicardial activation time is significantly prolonged in
Wnt GOF mice (4.4 ± 0.4 versus 11.5 ± 1.0 ms, n = 4 each genotype). (D–G) Representative electrical
activation pattern of the LV and RV during epicardial stimulation in control (D,E) and Wnt GOF (F,G)
mice. (H) Left ventricular (LV) longitudinal conduction velocity of Wnt GOF mice was slower during
stimulation at each cycle length, and the difference between the two genotypes became larger at faster
pacing rates (111 and 100 ms cycle lengths, n = 4). (I) Right ventricular (RV) longitudinal conduction
velocity of Wnt GOF mice was also slower, and was more severely decreased than in the LV. One Wnt
GOF mutant had an electrically inexcitable RV when paced at 143 ms cycle length, while two others had
markedly decreased conduction velocity at slower cycle lengths and became inexcitable at pacing rates
above 125 ms cycle interval. This is consistent with decremental conduction, a property of AV canal
and AV nodal tissues. Note the different time scales between each experiment. Data are represented as
mean ± SEM. Group comparison for conduction velocity was performed using a Student’s unpaired
2-tailed t-test at each cycle length. Group comparison for inexcitability was performed using a Chi
squared test without Yate’s correction. * p < 0.05. Modified from Gillers et al., Canonical Wnt Signaling
Regulates Atrioventricular Junction Programming and Electrophysiological Properties, Circulation Research,
Volume 116, Issue 3, page 402. http://circres.ahajournals.org/cgi/pmidlookup?view=long&pmid=25599332
In sum ary, optical map ing is a versatile technique t t li to the study of cardiac
electrical ctivi y at bo h the tissue and whole-organ level. The relative simplicity of the setup combined
with the availability of open-source analysis software has increased the avail bility and favorability of
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this technique to laboratories outside of the traditional EP field. A main disadvantage of this technique
is the inability to measure at multiple depths. Multi-photon microscopy has been recently used to
measure electrical activity and calcium transients simultaneously at varying tissue depths in intact
Langendorff-perfused hearts, allowing transmural EP differences to be studied with high spatial and
temporal resolution [36,37]. Although both techniques can only be performed on explanted hearts,
other techniques have been developed to allow measurement of cardiac electrical properties in vivo
and are discussed below.
4.8. Optogenetics
Optical mapping utilizes cardiotoxic voltage-sensitive dyes which limits the ability to perform
sequential experiments on a single sample ex vivo. Optogenetics combines the utility of
optical electrophysiology with genetics and circumvents the use of cardiotoxic dyes, enabling
electrophysiologic measurements in vivo through the use of genetically-encoded voltage indicators
(GEVIs). GEVIs are proteins that can sense voltage changes and have been genetically engineered
to express an indicator, such as fluorescence, in response to voltage changes. In addition to GEVIs,
genetically encoded calcium indicators (GECIs), such as GCaMP2, have been developed and utilized
to visualize Ca2+ transients and study conduction abnormalities in mice in vivo [38,39]. Optogenetics
can also provide an alternative to electrical stimulation or inhibition of cardiomyocyte depolarization
utilizing microbial opsins, called optogenetic actuators. Two such examples include channel rhodopsins
used to generate depolarizing/excitatory currents, and chloride pump halorhodopsin which can
generate a hyperpolarizing/inhibitory current. These actuators are single membrane-bound proteins
that can function as ion channels in complex with a form of Vitamin A (retinal) when exposed to
light [40,41]. This technique provides cell specificity and spatiotemporal precision in manipulating
cardiomyocyte stimulation. In 2010, Bruegmann et al. optimized and validated this method to
demonstrate optogenetic control of beating rate in embryonic stem cell-derived cardiomyocytes, as
well as in transgenic cardiac tissue [42]. Recently, several studies have shown optogenetic defibrillation
of ventricular tachycardia in mouse and rat models ex vivo, providing evidence for its potential
use in clinical cardiology [43–45]. However, major challenges for clinical application include—(i)
toxicity of the gene to be transferred; (ii) the requirement for endogenous retinal to form a functional
complex; (iii) an effective gene delivery method; and (iv) delivery of a light source compatible for each
individual heart.
4.9. Electrocardiographic Imaging (ECGI)
Electrocardiographic imaging (ECGI) is a non-invasive imaging procedure that can map electrical
activity on the cardiac epicardial surface in humans. A multi-electrode vest records 250 body-surface
electrocardiograms (ECGs), which can be combined with computed tomography (CT) or magnetic
resonance imaging (MRI) to provide cardiac geometry. This technology can provide patient-specific
activation maps and repolarization patterns of the epicardial surface and has been used to study
hereditary arrhythmias such as Long QT syndrome (LQTS) and BrS, as well as acquired arrhythmias
such as post-myocardial infarction ventricular tachycardia [46–49]. ECGI provides information on
both cardiac activation and repolarization, somewhat similar to optical mapping.
Zhang et al. used ECGI to delineate the cardiac electrophysiological substrate underlying the BrS
phenotype [48]. BrS patients exhibit delayed right ventricular outflow tract (RVOT) activation and
slow conduction, prolonged RVOT recovery time and activation-recovery intervals indicating delayed
repolarization, as well as steep repolarization gradients at RVOT borders (Figure 2). This study further
supports the concept that regional-specific changes in electrophysiologic substrate within the RVOT
underlie BrS. In addition to aiding our understanding of underlying mechanisms of arrhythmias, ECGI
has recently been used to non-invasively map ventricular tachycardia prior to delivery of radiation
for tachycardia ablation [50]. Given the wealth of information that can be gleaned non-invasively,
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we expect ECGI will gain more widespread use in both research and clinical applications tailored to
personalized therapies.




Figure 2. Activation and repolarization during sinus rhythm. (A) Activation times isochrone maps 
(AT). Insets, zoom on the RVOT. (B) Activation-recovery interval maps (ARI). (C) Recovery time (RT) 
maps. Epicardial breakthroughs are indicated by asterisks. Isochrones are depicted in thin black lines. 
Black arrows in the RVOT zoom maps of A point to slow conduction indicated by crowded isochronal 
lines. Red arrows in B and C point to regions with steep repolarization gradients. BrS indicates 
Brugada syndrome; LA, left atrium; LV, left ventricle; PT, pulmonary trunk; RA, right atrium; RV, 
right ventricle; and RVOT, right ventricular outflow tract. Modified from Zhang et al., Cardiac 
electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada 
syndrome patients, Circulation, Volume 131, Issue 22, page 1954. 
http://circ.ahajournals.org/content/131/22/1950.long 
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Figure 2. Activation and repolarization during sinus rhythm. (A) Activation times isochrone maps
(AT). Insets, zoom on the RVOT. (B) Activation-recovery interval maps (ARI). (C) Recovery time (RT)
maps. Epicardial breakthroughs are indicated by asterisks. Isochrones are depicted in thin black lines.
Black arrows in the RVOT zoom maps of A point to slow conduction indicated by crowded isochronal
lines. Red arrows in B and C point to regions with steep repolarization gradients. BrS indicates Brugada
syndrome; LA, left atrium; LV, left ventricle; PT, pulmonary trunk; RA, right atrium; RV, right ventricle;
and RVOT, right ventricular outflow tract. Modified from Zhang et al., Cardiac electrophysiological substrate
underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients, Circulation,
Volume 131, Issue 22, page 1954. http://circ.ahajournals.org/content/131/22/1950.long
5. Conclusions
In summary, the evolution of technology and experimentation has revealed a greater appreciation
of regional heterogeneity in the heart during health and disease. To fully understand the basis for
regulation of cardiac electrophysiology, it is imperative to integrate concepts and techniques from
diverse disciplines, including clinical cardiology, biomedical engineering, physiology, genomics,
and developmental biology. Filling these gaps in our knowledge is challenging and requires us to
understand several languages, but is nonetheless crucial to maximizing our collective understanding
and to prevent potential new insights from being “lost in translation”.
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